Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_assertion type Assertion NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_head.
- NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_assertion description "[It seems that genomic alterations within bcr and abl cannot account, alone, for the duration of the chronic phase of Ph1 positive CML and those quantitative and/or qualitative alterations of the p210 bcr/abl protein, unluckily awkward to prove, might be responsible for the atypical clinical features of these CML long survivors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_provenance.
- NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_assertion evidence source_evidence_literature NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_provenance.
- NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_assertion SIO_000772 2733455 NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_provenance.
- NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_assertion wasDerivedFrom befree-20140225 NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_provenance.
- NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_assertion wasGeneratedBy ECO_0000203 NP787618.RAy-zDCD3xLhoG1miKP2GpTOpHZ8dc5X_NJO-aID2IOP4130_provenance.